株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

細胞培地市場:試薬別、タイプ別、用途別、エンドユーザー別:世界の業界分析、規模、シェア、成長、動向、予測

Cell Culture Media Market; by Reagent Type ; by Type ; for Applications ; and by End-users : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

発行 Zion Market Research 商品コード 680101
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.74円で換算しております。
Back to Top
細胞培地市場:試薬別、タイプ別、用途別、エンドユーザー別:世界の業界分析、規模、シェア、成長、動向、予測 Cell Culture Media Market; by Reagent Type ; by Type ; for Applications ; and by End-users : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日: 2018年04月24日 ページ情報: 英文 110 Pages
概要

当レポートでは、世界の細胞培地市場について調査し、市場の現状と今後の成長予測、試薬別、タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場動向

  • イントロダクション
  • 市場促進因子
  • 市場阻害因子
  • 機会
  • ポーターズファイブフォース分析
  • 市場の魅力度分析

第4章 競合環境

  • 企業市場シェア分析
  • 戦略的発展
  • 製品ポートフォリオ

第5章 試薬別セグメント分析

  • 概要
  • アルブミン
  • ホルモン
  • 接合因子
  • 増殖因子とサイトカイン

第6章 タイプ別セグメント分析

  • 概要
  • 既知組成培地
  • 従来の培地
  • 溶原性ブロス
  • 無タンパク質培地
  • 無血清培地
  • 特殊培地

第7章 用途別セグメント分析

  • 概要
  • バイオ医薬品および治療薬
  • バイオテクノロジー研究
  • 薬剤スクリーニングと薬剤開発
  • 再生医療と組織エンジニアリング
  • 幹細胞技術

第8章 エンドユーザー別セグメント分析

  • 概要
  • バイオテクノロジー・製薬会社
  • 研究機関
  • 学術機関
  • 病理試験所

第9章 地域別セグメント分析

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

目次

Report Brief

  • The report covers forecast and analysis for the cell culture media market on a global, regional, and country level.
  • The report includes the positive and the negative factors that are influencing the growth of the market.
  • Future market opportunities and detailed information about the market are discussed.
  • The revenue generated by the prominent industry players has been analyzed in the report.
  • The market numbers have been calculated using top-down and the bottom-up approaches.
  • The cell culture media market has been analyzed using Porters Five Forces Analysis.
  • The market is segmented on the basis of reagent type, media type, applications, and end-user which in turn are bifurcated on a regional level as well.
  • All the segments have been evaluated based on the present and the future trends.
  • The report deals with the in-depth quantitative and qualitative analyses of the cell culture media market.
  • The report includes the detailed company profiles of the prominent market players.

Market Summary

The global cell culture media market is expected to grow significantly over the forecast period. Cell culture media are used for in vitro cultivation of cells. Culture media supports the growth of microorganisms such as bacteria or fungi which are further used for research and clinical studies for several applications. Increasing pharmaceutical and biotechnology industries, high return on investments, and advanced applications of in vitro cell culture are significantly propelling the growth of the cell culture media market.

Value

The global cell culture media was valued at around USD 676 million in the year 2017 and it is expected to reach approximately USD 1,394 million by 2026. The global cell culture media market is expected to exhibit a CAGR of more than 8.2% between 2018 and 2026.

Drivers and Restraints

The major factor driving the growth of cell culture media is the rising demand for treating chronic diseases in a customized way, which has increased the spending for cell culture development and is anticipated to drive the cell culture media market during the forecast period. Moreover, raising awareness about stem cell culture and its advanced applications in large-scale life science industries will also fuel the growth of the market during the forecast period. Moreover, the vast growth in biotechnology and pharmaceutical industrial activities worldwide and increasing spending in clinical research in developed as well as in developing economies is expected to drive the market during the forecast period.

However, to handle the cell culture process skilled personnel are required. Lack of skilled lab technicians and pharmacists in developing economies may limit the growth of the market. Unskilled lab technicians and pharmacists are unable to understand the proper protocol and system for in vitro cultivation which can affect the cell culture and its growth, resulting in the contamination of cell culture media, issues of reproducibility, the occurrence of heavy trace elements, and others thus posing as a challenge for the market.

Segmentation

Attachment factors segment accounted for the largest market share in 2017 and is expected to dominate the reagent segment during the forecast period. The major factor contributing to the significant growth of attachment factors segment is the increasing demand for in vitro cell cultivations. In albumin segment, the recombinant human serum albumin sub-segment anticipates accounting for 36.3% market share by 2026. Among the growth factor segment, the tumor necrosis factors sub-segment is expected to grow at the significant CAGR of 8.7% from 2018 to 2026.

Classical media segment by media type accounted for the largest market share in 2017 and is expected to dominate the market during the forecast period. Classical media are the most widely used and affordable media type which are used to grow several microorganisms, thus expected to hold a prominent market share throughout the forecast period. Lysogeny broth segment is anticipated to grow at the highest CAGR during the forecast period owing to its high adoption rate globally.

By applications, biopharmaceuticals and therapeutics segment accounted for the largest market share in 2017 and is expected to dominate the market by the end of forecast period. Increasing RD activities and the introduction of new protocols and technologies for cell culture process will significantly propel the growth of the market. However, the biotech research application segment is expected to grow at highest CAGR during the forecast period, owing to increasing biotechnology companies in developing countries.

Based on end-users, the biotechnology and pharmaceutical companies contributed the majority of the market share. The factors such as increasing in vitro clinical research and ongoing technological developments in biotech and pharmaceutical industries such as commercialization of stem cells will boost the segment during the forecast period.

North America contributes the largest share in the global cell culture media market. Increased government initiatives for research and clinical studies regarding chronic diseases such as cancer coupled with the presence of the well-developed biotechnology and pharmaceutical companies in the region will propel the growth of the market in North America during the forecast period. Europe holds the second largest share in global cell culture media market. High investments in research and biotech sectors, as well as the high adoption rate of new technologies, will lift the market in the European region. The Asia Pacific is anticipated to be the most lucrative region in the global cell culture media market owing to increasing biotechnology and pharmaceutical industries, technological developments in life science research, and rising initiatives for in vitro cultivations. Asia Pacific is expected to register the highest CAGR in the global cell culture media market. The increasing research base in China and India is expected to boost the growth of the market in the Asia Pacific.

Industry Players

The report includes detailed profiles of the prominent market players that are trending in the market. The list of the players that are compiled in the report are Analytical Biological Services Inc., Atlanta Biologicals, Inc., BD Biosciences, Cell Essentials, Inc., ClonTech Laboratories, Inc., GE Healthcare, JR Scientific, Inc., Life Technologies, Lonza Bioscience, Merck Millipore, MP Biomedicals, Novozymes Biopharma US Inc., Quality Biological, Inc., SeraCare Life Sciences, Inc., Siam Bioscience Co. Ltd., Sigma-Aldrich, Stemcell Technologies Inc., and Thermo Fisher Scientific, Inc., among others.

The growing strategic collaboration and partnership among the top players in the cell culture media market significantly contribute toward the growth of the market globally. For instance, in April 2017, the BD Biosciences signed a definitive agreement under which BD will acquire C.R. Bard, Inc. to create a highly differentiated medical technology company uniquely positioned to improve both the process of care and the treatment of disease for patients and healthcare providers.

In September 2017, the Bio-Techne Corporation acquired all of the stock of Trevigen Inc. in order to develop products and technologies for cancer research, drug discovery, genetic toxicology, regenerative medicine, and stem cell work.

Moreover, the increasing product launch by the top players of the cell culture media is expected to propel the growth of the market over the forecast period. For instance, in June 2015, Takara Bio launched an innovative iPS cell culture medium for pre-clinical use: Cellartis DEF-CS Xeno-Free Culture Medium.

Table Of Contents

Chapter 1. Introduction

  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology

Chapter 2. Executive Summary

  • 2.1. Global Cell Culture Media market, 2016 2026 (USD Million)
  • 2.2. Global Cell Culture Media market: Snapshot

Chapter 3. Cell Culture Media Market Dynamics

  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Cell Culture Media market drivers: Impact analysis
    • 3.2.2. Increases in expenditures for cell cultures
    • 3.2.3. Introduction of new RD products
  • 3.3. Market Restraints
    • 3.3.1. Global Cell Culture Media market restraints: Impact analysis
    • 3.3.2. Lack of Skilled Lab Technicians and Pharmacists In Developing Economies
  • 3.4. Opportunities
    • 3.4.1. Improving quality of media and accurate results will lift up the market
  • 3.5. Porters five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. Threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by reagent type segment
    • 3.6.2. Market attractiveness analysis, by type segment
    • 3.6.3. Market attractiveness analysis, by application segment
    • 3.6.4. Market attractiveness analysis, by end user segment
      • 3.6.4.1. Market attractiveness analysis, by regional segment

Chapter 4. Global Cell Culture Media market Competitive Landscape

  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Cell Culture Media market: company market share, 2016
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions Mergers
    • 4.2.2. New tool Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development, Therapy and Regional Expansion
  • 4.3. Product Portfolio

Chapter 5. Global Cell Culture Media market Reagent type Segment Analysis

  • 5.1. Global Cell Culture Media market: Reagent type overview
    • 5.1.1. Global Cell Culture Media market revenue share, by Reagent type, 2017 and 2026
  • 5.2. Albumin
    • 5.2.1. Global Albumin Market, 2016 2026(USD Million)
    • 5.2.2. Global Bovine Serum Albumin Market, 2016 2026(USD Million)
    • 5.2.3. Human Serum Albumin
    • 5.2.4. Recombinant Human Serum Albumin
  • 5.3. Hormones
    • 5.3.1. Global Hormones Market , 2016 2026(USD Million)
  • 5.4. Attachment Factors
    • 5.4.1. Global Attachment FactorsMarket , 2016 2026(USD Million)
  • 5.5. Attachment Factors
    • 5.5.1. Global Attachment FactorsMarket , 2016 2026(USD Million)
  • 5.6. Growth factors and Cytokines
    • 5.6.1. Global Growth factors and CytokinesMarket , 2016 2026(USD Million)
    • 5.6.2. Global Tumor necrosis factors market, 2016 2026(USD Million)
    • 5.6.3. Global Insulin-like growth factors market, 2016 2026(USD Million)
    • 5.6.4. Global InterferonsMarket , 2016 2026(USD Million)
    • 5.6.5. Global InterleukinsMarket , 2016 2026(USD Million)

Chapter 6. Global Cell Culture Media market Type Segment Analysis

  • 6.1. Global Cell Culture Media market: Type overview
    • 6.1.1. Global Cell Culture Media market revenue share, by Type, 2016 2022
  • 6.2. Chemically-defined media
    • 6.2.1. Global Cell Culture Media market forChemically-defined media, 2016 2026 (USD Million)
  • 6.3. Classical media
    • 6.3.1. Global Cell Culture Media market for Classical media, 2016 2026(USD Million)
  • 6.4. Lysogeny broth
    • 6.4.1. Global Cell Culture Media market for Lysogeny broth, 2016 2026(USD Million)
  • 6.5. Protein-free media
    • 6.5.1. Global Cell Culture Media market for Protein-free media, 2016 2026(USD Million)
  • 6.6. Serum-free media
    • 6.6.1. Global Cell Culture Media market for Serum-free media, 2016 2026(USD Million)
  • 6.7. Specialty media
    • 6.7.1. Global Cell Culture Media market for Specialty media, 2016 2026(USD Million)

Chapter 7. Global Cell Culture Media market Application Segment Analysis

  • 7.1. Global Cell Culture Media market: Application overview
    • 7.1.1. Global Cell Culture Media market revenue share, by Application, 2017 and 2026
  • 7.2. Biopharmaceuticals and Therapeutics
    • 7.2.1. Global Cell Culture Media market for Biopharmaceuticals and Therapeutics, 2016 2026 (USD Million)
  • 7.3. Biotech Research
    • 7.3.1. Global Cell Culture Media market for Biotech Research, 2016 2026(USD Million)
  • 7.4. Cancer
    • 7.4.1. Global Cell Culture Media market for Cancer, 2016 2026(USD Million)
  • 7.5. Drug Screening and Drug Development
    • 7.5.1. Global Cell Culture Media market for Drug Screening and Drug Development, 2016 2026(USD Million)
  • 7.6. Regenerative Medicine and Tissue Engineering
    • 7.6.1. Global Cell Culture Media market for Regenerative Medicine and Tissue Engineering, 2016 2026(USD Million)
  • 7.7. Stem Cell Technologies
    • 7.7.1. Global Cell Culture Media market for Stem Cell Technologies, 2016 2026(USD Million)

Chapter 8. Global Cell Culture Media market End-User Segment Analysis

  • 8.1. Global Cell Culture Media market: Application overview
    • 8.1.1. Global Cell Culture Media market revenue share, by End User, 2017 and 2026
  • 8.2. Biotechnology and Pharmaceutical companies
    • 8.2.1. Global Cell Culture Media market for Biotechnology and Pharmaceutical companies, 2016 2026 (USD Million)
  • 8.3. Research Laboratories
    • 8.3.1. Global Cell Culture Media market for Research Laboratories, 2016 2026(USD Million)
  • 8.4. Academic Institutes
    • 8.4.1. Global Cell Culture Media market for Academic Institutes, 2016 2026(USD Million)
  • 8.5. Pathology Labs
    • 8.5.1. Global Cell Culture Media market for Pathology Labs, 2016 2026(USD Million)

Chapter 9. Global Cell Culture Media market Regional Segment Analysis

  • 9.1. Global Cell Culture Media market: Regional overview
    • 9.1.1. Global Cell Culture Media market revenue share, by region, 2017 and 2026
  • 9.2. North America
    • 9.2.1. North America Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
    • 9.2.2. North America Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
    • 9.2.3. North America Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
    • 9.2.4. North America Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.2.5. U.S. Cell Culture Media market revenue, 2016 2026 (USD Million)
      • 9.2.5.1. U.S.Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.2.5.2. U.S.Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.2.5.3. U.S.Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.2.5.4. U.S.Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.2.6. Rest of North America Cell Culture Media market revenue, 2016 2026 (USD Million)
      • 9.2.6.1. Rest of North America Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.2.6.2. Rest of North America Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.2.6.3. Rest of North America Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.2.6.4. Rest of North America Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Cell Culture Media market revenue, by Reagent type, 2016 2026(USD Million)
    • 9.3.2. Europe Cell Culture Media market revenue, by Type, 2016 2026(USD Million)
    • 9.3.3. Europe Cell Culture Media market revenue, by Application, 2016 2026(USD Million)
    • 9.3.4. Europe Cell Culture Media market revenue, by End User, 2016 2026(USD Million)
    • 9.3.5. Germany Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.3.5.1. Germany Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.3.5.2. Germany Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.3.5.3. Germany Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.3.5.4. Germany Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.3.6. UK Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.3.6.1. UK Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.3.6.2. UK Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.3.6.3. UK Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.3.6.4. UK Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.3.7. France Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.3.7.1. France Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.3.7.2. France Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.3.7.3. France Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.3.7.4. France Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.3.8. Italy Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.3.8.1. Italy Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.3.8.2. Italy Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.3.8.3. Italy Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.3.8.4. Italy Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.3.9. Spain Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.3.9.1. Spain Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.3.9.2. Spain Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.3.9.3. Spain Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.3.9.4. Spain Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.3.10. Rest of Europe Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.3.10.1. Rest of Europe Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.3.10.2. Rest of Europe Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.3.10.3. Rest of Europe Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.3.10.4. Rest of Europe Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Cell Culture Media market revenue, by Reagent type, 2016 2026, (USD Million)
    • 9.4.2. Asia Pacific Cell Culture Media market revenue, by Type, 2016 2026, (USD Million)
    • 9.4.3. Asia Pacific Cell Culture Media market revenue, by Application, 2016 2026(USD Million)
    • 9.4.4. Asia Pacific Cell Culture Media market revenue, by End User, 2016 2026(USD Million)
    • 9.4.5. China Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.4.5.1. China Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.4.5.2. China Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.4.5.3. China Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.4.5.4. China Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.4.6. Japan Cell Culture Media market revenue,2016 2026(USD Million)
      • 9.4.6.1. Japan Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.4.6.2. Japan Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.4.6.3. Japan Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.4.6.4. Japan Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.4.7. China Cell Culture Media market revenue,2016 2026(USD Million)
      • 9.4.7.1. China Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.4.7.2. China Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.4.7.3. China Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.4.7.4. China Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.4.8. India Cell Culture Media market revenue,2016 2026(USD Million)
      • 9.4.8.1. India Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.4.8.2. India Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.4.8.3. India Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.4.8.4. India Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.4.9. Southeast Asia Cell Culture Media market revenue,2016 2026(USD Million)
      • 9.4.9.1. Southeast Asia Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.4.9.2. Southeast Asia Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.4.9.3. Southeast Asia Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.4.9.4. Southeast Asia Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.4.10. Rest of Asia Pacific Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.4.10.1. Rest of Asia Pacific Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.4.10.2. Rest of Asia Pacific Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.4.10.3. Rest of Asia Pacific Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.4.10.4. Rest of Asia Pacific Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Cell Culture Media market revenue, by Reagent type, 2016 2026(USD Million)
    • 9.5.2. Latin America Cell Culture Media market revenue, by Type, 2016 2026(USD Million)
    • 9.5.3. Latin America Cell Culture Media market revenue, by Application, 2016 2026(USD Million)
    • 9.5.4. Latin America Cell Culture Media market revenue, by End User, 2016 2026(USD Million)
    • 9.5.5. Brazil Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.5.5.1. Brazil Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.5.5.2. Brazil Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.5.5.3. Brazil Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.5.5.4. Brazil Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.5.6. Rest of Latin America Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.5.6.1. Rest of Latin America Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.5.6.2. Rest of Latin America Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.5.6.3. Rest of Latin America Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.5.6.4. Rest of Latin America Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
    • 9.6.2. Middle East and Africa Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
    • 9.6.3. Middle East and Africa Cell Culture Media market revenue, by Application, 2016 2026(USD Million)
    • 9.6.4. Middle East and Africa Cell Culture Media market revenue, by End User, 2016 2026(USD Million)
    • 9.6.5. GCC Countries Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.6.5.1. Rest of Latin America Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.6.5.2. Rest of Latin America Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.6.5.3. Rest of Latin America Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.6.5.4. Rest of Latin America Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.6.6. Southern Africa Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.6.6.1. Southern Africa Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.6.6.2. Southern Africa Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.6.6.3. Southern Africa Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.6.6.4. Southern Africa Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)
    • 9.6.7. Rest of Middle East and Africa Cell Culture Media market revenue, 2016 2026(USD Million)
      • 9.6.7.1. Rest of Middle East and Africa Cell Culture Media market revenue, by Reagent type, 2016 2026 (USD Million)
      • 9.6.7.2. Rest of Middle East and Africa Cell Culture Media market revenue, by Type, 2016 2026 (USD Million)
      • 9.6.7.3. Rest of Middle East and Africa Cell Culture Media market revenue, by Application, 2016 2026 (USD Million)
      • 9.6.7.4. Rest of Middle East and Africa Cell Culture Media market revenue, by End User, 2016 2026 (USD Million)

Chapter 10. Company Profile

  • 10.1. Merck KGaA
    • 10.1.1. Overview
    • 10.1.2. Financials
    • 10.1.3. Product portfolio
    • 10.1.4. Business strategy
    • 10.1.5. Recent developments
  • 10.2. BD Biosciences
    • 10.2.1. Overview
    • 10.2.2. Financials
    • 10.2.3. Product portfolio
    • 10.2.4. Business strategy
    • 10.2.5. Recent developments
  • 10.3. Cell Essentials, Inc.
    • 10.3.1. Overview
    • 10.3.2. Financials
    • 10.3.3. Product portfolio
    • 10.3.4. Business strategy
    • 10.3.5. Recent developments
  • 10.4. Quality Biological, Inc.
    • 10.4.1. Overview
    • 10.4.2. Financials
    • 10.4.3. Product portfolio
    • 10.4.4. Business strategy
    • 10.4.5. Recent developments
  • 10.5. Bio-Techne Corporation (Atlanta Biologicals, Inc.)
    • 10.5.1. Overview
    • 10.5.2. Financials
    • 10.5.3. Product portfolio
    • 10.5.4. Business strategy
    • 10.5.5. Recent developments
  • 10.6. Affymetrix, Inc.
    • 10.6.1. Overview
    • 10.6.2. Financials
    • 10.6.3. Product portfolio
    • 10.6.4. Business strategy
    • 10.6.5. Recent developments
  • 10.7. SIAM Bioscience
    • 10.7.1. Overview
    • 10.7.2. Financials
    • 10.7.3. Product portfolio
    • 10.7.4. Business strategy
    • 10.7.5. Recent developments
  • 10.8. Novozymes A/S
    • 10.8.1. Overview
    • 10.8.2. Financials
    • 10.8.3. Product portfolio
    • 10.8.4. Business strategy
    • 10.8.5. Recent developments
  • 10.9. Novozymes A/S
    • 10.9.1. Overview
    • 10.9.2. Financials
    • 10.9.3. Product portfolio
    • 10.9.4. Business strategy
    • 10.9.5. Recent developments
  • 10.10. Thermo Fisher Scientific, Inc.
    • 10.10.1. Overview
    • 10.10.2. Financials
    • 10.10.3. Product portfolio
    • 10.10.4. Business strategy
    • 10.10.5. Recent developments
  • 10.11. ClonTech Laboratories, Inc.(Takara Bio USA, Inc.)
    • 10.11.1. Overview
    • 10.11.2. Financials
    • 10.11.3. Product portfolio
    • 10.11.4. Business strategy
    • 10.11.5. Recent developments
  • 10.12. Analytical Biological Services Inc.
    • 10.12.1. Overview
    • 10.12.2. Financials
    • 10.12.3. Product portfolio
    • 10.12.4. Business strategy
    • 10.12.5. Recent developments
  • 10.13. J R Scientific Inc.
    • 10.13.1. Overview
    • 10.13.2. Financials
    • 10.13.3. Product portfolio
    • 10.13.4. Business strategy
    • 10.13.5. Recent developments
  • 10.14. MP Biomedicals
    • 10.14.1. Overview
    • 10.14.2. Financials
    • 10.14.3. Product portfolio
    • 10.14.4. Business strategy
    • 10.14.5. Recent developments
  • 10.15. SeraCare Life Sciences, Inc.
    • 10.15.1. Overview
    • 10.15.2. Financials
    • 10.15.3. Product portfolio
    • 10.15.4. Business strategy
    • 10.15.5. Recent developments
  • 10.16. Stemcell Technologies Inc.
    • 10.16.1. Overview
    • 10.16.2. Financials
    • 10.16.3. Product portfolio
    • 10.16.4. Business strategy
    • 10.16.5. Recent developments
  • 10.17. Lonza
    • 10.17.1. Overview
    • 10.17.2. Financials
    • 10.17.3. Product portfolio
    • 10.17.4. Business strategy
    • 10.17.5. Recent developments
  • 10.18. GE Healthcare
    • 10.18.1. Overview
    • 10.18.2. Financials
    • 10.18.3. Product portfolio
    • 10.18.4. Business strategy
    • 10.18.5. Recent developments
Back to Top